Alan Sandler, MD
Genentech, a leading biotechnology company, is dedicated to bringing personalized cancer immunotherapy to patients, which means each person would have a treatment tailored to harness their own immune system to fight cancer. Scientists are studying atezolizumab (pronounced "a-tez-o-liz-u-mab") in multiple cancer types including lung, kidney, breast and bladder cancers.
In fact, Genentech just announced findings that atezolizumab shrank tumors in people with a certain type of advanced lung cancer. These data are important because it is estimated that 60 percent of lung cancer diagnoses in the United States are made when the disease is in the advanced stages. Immunotherapy is the latest advancement in cancer treatment; a topic I know is of interest to your readers. Alan Sandler, MD joins Lisa to chat about this.
|« Rajiv Sharma, MD||MD Medicine Shows||Dr David Agus Author of The Lucky Years »|